Showing results (91-100 of 494) with videos related to
Sort By:
Pageof 50
Pediatrics|September 4, 2024
The RACE Act and Pediatric Trials of Adult Cancer DrugsIan T T Liu, Aaron S KesselheimJAMA Internal Medicine|August 25, 2015
Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014Jing Luo, Jerry Avorn, Aaron S KesselheimPlos One|February 18, 2014
Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovationAaron S Kesselheim, Shuai Xu, Jerry AvornJAMA|August 24, 2016
The High Cost of Prescription Drugs in the United States: Origins and Prospects for ReformAaron S Kesselheim, Jerry Avorn, Ameet SarpatwariThe Journal of Pediatrics|July 26, 2024
Clinical Benefit and Revenues of Drugs Affected by Rare Pediatric Disease Priority Review Vouchers, 2017-2023Ian T T Liu, Aaron S KesselheimClinical Pharmacology and Therapeutics|December 23, 2017
Prevalence of Publicly Available Expanded Access PoliciesEmily Jung, Patricia J Zettler, Aaron S KesselheimHealth Affairs (Project Hope)|July 13, 2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policyAaron S Kesselheim, Michael A Fischer, Jerry AvornJAMA Network Open|January 16, 2019
A Comparison of Response Patterns for Progression-Free Survival and Overall Survival Following Treatment for Cancer With PD-1 Inhibitors: A Meta-analysis of Correlation and Differences in Effect SizesBishal Gyawali, Spencer Phillips Hey, Aaron S KesselheimThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 16, 2025
Overlapping Method of Use Patents to Prevent Generic EntryJin Park, Aaron S Kesselheim, S Sean TuJAMA Internal Medicine|September 12, 2017
Determinants of Market Exclusivity for Prescription Drugs in the United StatesAaron S Kesselheim, Michael S Sinha, Jerry AvornPageof 50